Search results

Page results

• Mixed sex accommodation and privacy

  Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay

• UCLH recruits first patient globally for new Alzheimer’s Disease trial

  UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.

• Steroid treatment for inflammation caused by immunotherapy

  This information is for patients receiving steroids for immunotherapy toxicity.

• Study reveals limitations of drug proposed for lung cancer treatment

  Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.

• Infectious disease update during COVID-19

  All GPs are now welcome to use our national Infectious & Tropical Disease Advice and Guidance function on the e-referral system (NHS e-RS)

• Outpatients clinics during COVID-19

  Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.

• WEB Intracranial aneurysm device in the treatment of cerebral aneurysms

  This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms

• UCLH recruits first participant in Europe to remdesivir outpatient study

  UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.

• World’s first COVID-19 vaccine alternating dose study launches at UCLH

  The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.

• 'Gamechanger' drug for treating obesity cuts body weight by 20%

  In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.